Federal Register of Legislation - Australian Government

Primary content

PB 76 of 2020 Determinations/Health as made
This instrument determines that section 99ACB(1) is taken not to have applied to MERCAPTOPURINE-LINK brand of mercaptopurine, tablet containing mercaptopurine monohydrate 50 mg, oral, effective from 1 August 2020.
Administered by: Health
Registered 31 Jul 2020
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 76 of 2020

 

National Health (subsection 99ACB(1) taken not to have applied) Determination 2020

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following determination.

Dated   30        July 2020                    

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Definitions................................................................................................................................ 1

5  Subsection 99ACB(1) is taken not to have applied.................................................................. 1

 

 


1  Name

                   This instrument is the National Health (subsection 99ACB(1) taken not to have applied) Determination 2020.

                   This instrument may also be cited as PB 76 of 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 August 2020.

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under section 99AEI of the National Health Act 1953.

4  Definitions

                   In this instrument:

Act means the National Health Act 1953.

5  Subsection 99ACB(1) is taken not to have applied 

             (1)  For the purposes of subsection 99ACB(3) of the Act, subsection 99ACB(1) of the Act is taken not to have applied to the MERCAPTOPURINE-LINK brand of mercaptopurine, tablet containing mercaptopurine monohydrate 50 mg, oral.